DE59814211D1 - Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie - Google Patents

Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Info

Publication number
DE59814211D1
DE59814211D1 DE59814211T DE59814211T DE59814211D1 DE 59814211 D1 DE59814211 D1 DE 59814211D1 DE 59814211 T DE59814211 T DE 59814211T DE 59814211 T DE59814211 T DE 59814211T DE 59814211 D1 DE59814211 D1 DE 59814211D1
Authority
DE
Germany
Prior art keywords
cation exchange
exchange chromatography
factor viii
vwf complex
cleaning factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59814211T
Other languages
German (de)
English (en)
Inventor
Artur Mitterer
Bernhard Fischer
Oeyvind L Schoenberger
Kathrin Thomas-Urban
Friedrich Dorner
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3487946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59814211(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of DE59814211D1 publication Critical patent/DE59814211D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE59814211T 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie Expired - Lifetime DE59814211D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033897A AT406373B (de) 1997-02-27 1997-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
PCT/AT1998/000043 WO1998038220A1 (de) 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Publications (1)

Publication Number Publication Date
DE59814211D1 true DE59814211D1 (de) 2008-05-21

Family

ID=3487946

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59814211T Expired - Lifetime DE59814211D1 (de) 1997-02-27 1998-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Country Status (11)

Country Link
US (3) US6831159B1 (https=)
EP (1) EP0971958B2 (https=)
JP (1) JP4250771B2 (https=)
AR (2) AR010121A1 (https=)
AT (2) AT406373B (https=)
AU (1) AU744919B2 (https=)
CA (1) CA2282841C (https=)
DE (1) DE59814211D1 (https=)
ES (1) ES2306471T5 (https=)
NO (2) NO324902B1 (https=)
WO (1) WO1998038220A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
EP2349314B1 (en) 2008-10-21 2013-02-27 Baxter International Inc. Lyophilized recombinant vwf formulations
DK2467399T3 (en) 2009-08-20 2017-01-23 Baxalta Inc Purification of vWF for increased removal of non-lipid-enveloped viruses
WO2011060242A2 (en) 2009-11-13 2011-05-19 Talecris Biotherapeutics, Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
KR101619865B1 (ko) 2010-07-30 2016-05-11 이엠디 밀리포어 코포레이션 크로마토그래피 매질
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
DK3412305T3 (da) * 2011-06-10 2021-03-01 Baxalta GmbH Behandling af koagulationssygdom ved administration af rekombinant vwf
US9534037B2 (en) 2011-08-02 2017-01-03 Baxalta GmbH Systems and methods to increase protein yield from recombinant manufacturing processes
PL2861059T3 (pl) 2012-06-15 2017-10-31 Commw Scient Ind Res Org Wytwarzanie długołańcuchowych wielonienasyconych kwasów tłuszczowych w komórkach roślinnych
EP2925777B1 (en) * 2012-11-30 2019-05-01 Centre for Bioseparation Technology-VIT Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
CN105705516B (zh) * 2013-11-08 2019-11-01 杰特有限公司 浓缩von Willebrand因子或其络合物的方法
NZ721036A (en) 2013-12-18 2023-07-28 Grains Res & Dev Corp Lipid comprising long chain polyunsaturated fatty acids
PH12016502586B1 (en) 2014-06-27 2023-07-19 Commw Scient Ind Res Org Lipid comprising docosapentaenoic acid
EP3188816B1 (en) 2014-09-02 2021-06-09 EMD Millipore Corporation Chromatography media comprising discrete porous bundles of nanofibrils
EP3230299A1 (en) 2014-12-08 2017-10-18 EMD Millipore Corporation Mixed bed ion exchange adsorber
EP4424366A3 (en) 2017-07-07 2024-12-04 Takeda Pharmaceutical Company Limited Treatment of gastrointestinal bleeding in patients with severe von willebrand disease by administration of recombinant vwf
EA202192140A1 (ru) 2019-02-01 2021-12-15 Такеда Фармасьютикал Компани Лимитед СПОСОБЫ ПРОФИЛАКТИЧЕСКОГО ЛЕЧЕНИЯ РЕКОМБИНАНТНЫМ ФВ (рФВ)
CN114106145B (zh) * 2021-10-22 2023-09-01 山东泰邦生物制品有限公司 一种血源人凝血因子ⅷ/血管性血友病因子复合物生产工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
NZ237244A (en) * 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) * 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) * 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) * 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
CA2251558C (en) 1996-04-12 2005-11-22 Immuno Aktiengesellschaft Highly purified factor viii complex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Also Published As

Publication number Publication date
JP4250771B2 (ja) 2009-04-08
CA2282841C (en) 2008-12-02
NO994137L (no) 1999-08-26
CA2282841A1 (en) 1998-09-03
NO324902B1 (no) 2007-12-27
US6953837B2 (en) 2005-10-11
ES2306471T3 (es) 2008-11-01
EP0971958B1 (de) 2008-04-09
ATA33897A (de) 1999-09-15
US6831159B1 (en) 2004-12-14
NO20071357L (no) 1999-08-26
NO326257B1 (no) 2008-10-27
AR059902A2 (es) 2008-05-07
AT406373B (de) 2000-04-25
ATE391728T1 (de) 2008-04-15
AU744919B2 (en) 2002-03-07
EP0971958A1 (de) 2000-01-19
US20050239171A1 (en) 2005-10-27
ES2306471T5 (es) 2012-06-07
EP0971958B2 (de) 2012-02-08
JP2001517212A (ja) 2001-10-02
US20020058625A1 (en) 2002-05-16
NO994137D0 (no) 1999-08-26
US7648958B2 (en) 2010-01-19
WO1998038220A1 (de) 1998-09-03
AU6080698A (en) 1998-09-18
AR010121A1 (es) 2000-05-17

Similar Documents

Publication Publication Date Title
DE59814211D1 (de) Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
DE59809522D1 (de) Verfahren zur Steuerung von Koordinatenmessgeräten nach Solldaten
DE69522868D1 (de) Verfahren zum Herstellen von Äthylen
DE69609138D1 (de) Verfahren zum Herstellen von Komponenten für absorbierende Erzeugnisse
DE69504534D1 (de) Verfahren zur herstellung von profilierungseinrichtungen für reliefartige oberflächen
DE69634732D1 (de) Verfahren zur reinigung von bürsten
DE69502053D1 (de) Verfahren zur Reinigung der Akrylsäure
ATE307824T1 (de) Verfahren für die reinigung von interferon- proteinen mittels kationen- austauschchromatographie
EP0791095A4 (en) Method of cleaning carpets
DE59813666D1 (de) Verfahren zum Herstellen von schalenförmigen Verzehrgütern
DE59813968D1 (de) VERFAHREN ZUR GEWINNUNG VON HOCHREINEM vWF ODER FACTOR VIII/vWF-KOMPLEX
DE69935929D1 (de) Verfahren zur reinigung von blutbestandteilen
DE69502137D1 (de) Verfahren zur Methathesis von Olefinen
DE69502997D1 (de) Verfahren zum Herstellen von Bürsten
DE69630559D1 (de) Verfahren zum Beschichten von Flachglas
DE69406275D1 (de) Kontinuierliches verfahren zur reinigung von perfluorchemischen zusammensetzungen
DE59406706D1 (de) Verfahren zum Reinigen von Hohlfasern
DE69709695T8 (de) Verfahren zur seitenzusammensetzung
DE69529854D1 (de) Verfahren zum Reinigen von Melkbechern
DE59711732D1 (de) Reinigung von faktor viii-komplex durch immunaffinitätschromatographie
DE69324728D1 (de) Verfahren zur Reinigung von Phenol
DE69807148D1 (de) Verfahren zur Hydroformylierung von Olefininen
DE69516317D1 (de) Verfahren zur Reinigung von Fullerenen
DE59503156D1 (de) Verfahren zur Aufarbeitung von komplexen Aminhydrofluoriden
DE69807371D1 (de) Verfahren zur Reinigung von Flüssigkristallen

Legal Events

Date Code Title Description
8363 Opposition against the patent
R082 Change of representative

Ref document number: 971958

Country of ref document: EP

Representative=s name: BIRD & BIRD LLP, DE